News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Senesco Technologies, Inc. (SNT) Announces Presentation On The Effectiveness Of eIF5A In Inhibiting Tumor Progression In Liver Cancer Models


4/28/2014 9:05:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTC QB:SNTI), announced today that an oral presentation will be delivered on its potential approach to treating hepatocellular carcinoma at the 17th Annual Meeting of the American Society of Gene & Cell Therapy during the session entitled “Cancer-Targeted Gene & Cell Therapy II”.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES